Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Licette CY Liu, Elise Schutte, Ron T Gansevoort, Peter van der Meer & Adriaan A Voors. (2015) Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease. Expert Opinion on Investigational Drugs 24:8, pages 1123-1135.
Read now
Read now
Articles from other publishers (23)
Sarah Bayne, James LeFevre, Kayla Olstinske, Sreenithya Ravindran & Shankar Munusamy. (2023) Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease. Advanced Biology.
Crossref
Crossref
Michael Crompton, Laura J. Skinner, Simon C. Satchell & Matthew J. Butler. (2023) Aldosterone: Essential for Life but Damaging to the Vascular Endothelium. Biomolecules 13:6, pages 1004.
Crossref
Crossref
Esra Baskin, Meraj Alam Siddiqui, Kaan Gülleroğlu, Binnaz Handan Özdemir, Aysun Çaltık Yılmaz, Meriç Yavuz Çolak, Aydıncan Akdur, Ebru Ayvazoğlu Soy, Gökhan Moray & Mehmet Haberal. (2023) Long‐term effect of eplerenone treatment in children with chronic allograft nephropathy. Pediatric Transplantation.
Crossref
Crossref
Peter Chun-Yip Tong, Susanna Chi-Pun Chan, Wing-Bun Chan, Kelvin Kai-Leung Ho, Godwin Tat-Chi Leung, Stanley Hok-King Lo, Gary Yiu-Kwong Mak & Tak-Sun Tse. (2023) Consensus Statements from the Diabetologists & Endocrinologists Alliance for the Management of People with Hypertension and Type 2 Diabetes Mellitus. Journal of Clinical Medicine 12:10, pages 3403.
Crossref
Crossref
Yu-Cheng Lu, Kao-Lang Liu, Vin-Cent Wu, Shuo-Meng Wang, Yen-Hung Lin, Shih-Chieh Jeff Chueh, Kwan-Dun Wu, Yann-Rong Su & Kuo-How Huang. (2023) Unilateral adrenalectomy in bilateral adrenal hyperplasia with primary aldosteronism. Journal of the Formosan Medical Association 122:5, pages 393-399.
Crossref
Crossref
Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda & Setsuko Iijima. (2020) Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction. Hypertension Research 44:5, pages 489-497.
Crossref
Crossref
Juan Martínez-Milla, Marcelino Cortés García, Mikel Taibo Urquía, Marta López Castillo, Ana Devesa Arbiol, Ana Lucía Rivero Monteagudo, María Luisa Martín Mariscal, Sem Briongos Figuero, Juan Antonio Franco-Pelaéz & José Tuñón. (2019) Blockade of Renin–Angiotensin–Aldosterone System in Elderly Patients with Heart Failure and Chronic Kidney Disease: Results of a Single-Center, Observational Cohort Study. Drugs & Aging 36:12, pages 1123-1131.
Crossref
Crossref
Martin H. Keppel, Grzegorz Piecha, Winfried März, Janne Cadamuro, Simon Auer, Thomas K. Felder, Cornelia Mrazek, Hannes Oberkofler, Christian Trummer, Martin R. Grübler, Verena Schwetz, Nicolas Verheyen, Marlene Pandis, Valentin Borzan, Elisabeth Haschke-Becher, Andreas Tomaschitz & Stefan Pilz. (2019) The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension. PLOS ONE 14:2, pages e0212973.
Crossref
Crossref
Jee Young LeeHyoungnae KimHyung Woo KimGeun Woo RyuYooju NamSeonyeong LeeYoung Su JooSangmi LeeJung Tak ParkSeung Hyeok HanShin-Wook KangTae-Hyun YooHae-Ryong Yun. (2019) Incidence of Acute Kidney Injury after Adrenalectomy in Patients with Primary Aldosteronism. Electrolytes & Blood Pressure 17:2, pages 45.
Crossref
Crossref
Kuo-How Huang, Chih-Chin Yu, Ya-Hui Hu, Chin-Chen Chang, Chieh-Kai Chan, Shih-Cheng Liao, Yao-Chou Tsai, Shih-Chieh Jeff Chueh, Vin-Cent Wu, Yen-Hung Lin, Vin-Cent Wu, Jui-Hsiang Lin, Wei-Jie Wang, Che-Hsiung Wu, Ya-Hui Hu, Leay Kiaw Er, Chia-Hui Chang, Ya-Li Chang, Yao-Chou Tsai, Chih-Chin Yu, Yen-Hung Lin, Yi-Luwn Ho, Hung-Wei Chang, Lian-Yu Lin, Fu-Chang Hu, Chin-Chen Chang, Kao-Lang Liu, Shuo-Meng Wang, Kuo-How Huang, Shih-Chieh Jeff Chueh, Shih-Cheng Liao, Ching-Chu Lu, Ruoh-Fang Yen & Kwan-Dun Wu. (2019) Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism. Journal of the Formosan Medical Association 118:1, pages 72-82.
Crossref
Crossref
Sophie Girerd, Luc Frimat, Didier Ducloux, Yannick Le Meur, Christophe Mariat, Bruno Moulin, Christiane Mousson, Philippe Rieu, Nassim Dali-Youcef, Ludovic Merckle, Xavier Lepage, Patrick Rossignol, Nicolas Girerd & Frédéric Jaisser. (2018) EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial. Trials 19:1.
Crossref
Crossref
Mary E. Haas, Krishna G. Aragam, Connor A. Emdin, Alexander G. Bick, Gibran Hemani, George Davey Smith & Sekar Kathiresan. (2018) Genetic Association of Albuminuria with Cardiometabolic Disease and Blood Pressure. The American Journal of Human Genetics 103:4, pages 461-473.
Crossref
Crossref
Ganesh Pathare, Manuel Anderegg, Giuseppe Albano, Florian Lang & Daniel G. Fuster. (2018) Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC). Scientific Reports 8:1.
Crossref
Crossref
Iacopo Chiodini, Claudia Battista, Elisa Cairoli, Cristina Eller-Vainicher, Valentina Morelli, Serena Palmieri, Antonio Stefano Salcuni & Alfredo Scillitani. 2018. Multidisciplinary Approach to Osteoporosis. Multidisciplinary Approach to Osteoporosis
107
128
.
Milton Packer. (2017) Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure. Circulation 136:16, pages 1548-1559.
Crossref
Crossref
Bingbing Zhang, Anja T. Umbach, Hong Chen, Jing Yan, Hajar Fakhri, Abul Fajol, Madhuri S. Salker, Daniela Spichtig, Arezoo Daryadel, Carsten A. Wagner, Michael Föller & Florian Lang. (2016) Up-regulation of FGF23 release by aldosterone. Biochemical and Biophysical Research Communications 470:2, pages 384-390.
Crossref
Crossref
Jing Xiao, Weijun Chen, Yijun Lu, Xiaoli Zhang, Chensheng Fu, Zhenwen Yan, Zhenxing Zhang & Zhibin Ye. (2015) Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell. Inflammation Research 64:8, pages 603-614.
Crossref
Crossref
Ferruh Artunc & Florian Lang. (2014) Mineralocorticoid and SGK1-Sensitive Inflammation and Tissue Fibrosis. Nephron Physiology 128:1-2, pages 35-39.
Crossref
Crossref
Florian Lang. (2014) On the Pleotropic Actions of Mineralocorticoids. Nephron Physiology 128:1-2, pages 1-7.
Crossref
Crossref
Hyun-Woo Kim, Hyunkyoung Park, Kyung Hwan Cho, Kyungdo Han & Byung-Joon Ko. (2014) Parathyroid hormone, vitamin D levels and urine albumin excretion in older persons: the 2011 Korea National Health and Nutrition Examination Survey (KNHANES). Clinical Endocrinology 80:1, pages 34-40.
Crossref
Crossref
Romain Eschalier, John J.V. McMurray, Karl Swedberg, Dirk J. van Veldhuisen, Henry Krum, Stuart J. Pocock, Harry Shi, John Vincent, Patrick Rossignol, Faiez Zannad & Bertram Pitt. (2013) Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function. Journal of the American College of Cardiology 62:17, pages 1585-1593.
Crossref
Crossref
Tian-Biao Zhou, Sheng-Sheng Yin & Rong Liang. (2012) A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. Journal of the Renin-Angiotensin-Aldosterone System 14:3, pages 235-241.
Crossref
Crossref
Bård Waldum & Ingrid Os. (2013) The Cardiorenal Syndrome: What the Cardiologist Needs to Know. Cardiology 126:3, pages 175-186.
Crossref
Crossref